Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7943
+0.0051 (0.65%)
Sep 18, 2026, 1:36 PM EDT - Market open
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $68.52 million as of September 18, 2026. Its market cap has increased by 155.67% in one year.
Market Cap
68.52M
Enterprise Value
27.87M
1-Year Change
155.67%
Ranking
Category
Stock Price
$0.79
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $68.52M, a decrease of -56.87%. That is a compound annual growth rate of -8.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 68.52M | 124.72% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 72.96M |
| Acrivon Therapeutics | 72.85M |
| Eloxx Pharmaceuticals | 72.07M |
| Pliant Therapeutics | 69.97M |
| Champions Oncology | 69.87M |
| OKYO Pharma | 69.27M |
| Alps Group | 66.54M |
| Alterity Therapeutics | 66.12M |